Evaluation of A Reproductive Health Education Program in Women Living With HIV

February 17, 2026 updated by: Özlem Akgöl, Okan University

Evaluation of the Reproductive Health Education Program Prepared According to Pender's Health Promotion Model in Women Living With Human Immunodeficiency Virus (HIV)

This study was conducted to evaluate the effectiveness of a reproductive health education program designed and implemented using Pender's Health Promotion Model for women living with HIV.The study was designed as a prospective controlled experimental study.

The hypotheses tested in the study include the following questions:

  • Does a "Reproductive Health Education Program" prepared using the Health Promotion Model for women living with HIV increase the reproductive health knowledge level of HIV-positive women?
  • Does a "Reproductive Health Education Program" prepared using the Health Promotion Model for women living with HIV positively influence healthy lifestyle behaviors related to women's health among HIV-positive women?
  • Does a "Reproductive Health Education Program" prepared using the Health Promotion Model for women living with HIV positively influence lifestyle behaviors related to general health among HIV-positive women?

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

No

Description

Sampling Inclusion Criteria

  • Female individuals
  • Individuals diagnosed with HIV
  • Individuals aged 18-49 years
  • Sexually active individuals

Sample Exclusion Criteria

  • Being pregnant
  • Being postpartum
  • Individuals with disabilities
  • Individuals whose gender identity does not match their biological sex at birth, those receiving hormonal therapy, or other conditions that do not fit the specific biological focus of the study.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Control
Experimental: Experimental
a reproductive health education program
Behavioral: a reproductive health education program
The Health Promotion Model used in the study. The first module was the "Women's Reproductive Health-Sexual Health Module," and the second module was the "HIV/AIDS Healthy Lifestyle Behaviors Module.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The Scale for Determining the Reproductive Health Preventive Attitudes of Married Women
Time Frame: From enrollment to the end of education modules at 4 weeks
It is a 5-point Likert-type scale consisting of a total of 39 items. The scale scores range from 39 to 195. The increase in scores indicates that women's attitudes and behaviors regarding protecting their reproductive health are positive.
From enrollment to the end of education modules at 4 weeks
AIDS/HIV Knowledge
Time Frame: From enrollment to the end of education modules at 4 weeks
AIDS/HIV Knowledge Scale
From enrollment to the end of education modules at 4 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Okan University

Investigators

  • Study Chair: Kenan Oztop, Okan University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 1, 2020

Primary Completion (Actual)

July 1, 2021

Study Completion (Actual)

June 1, 2022

Study Registration Dates

First Submitted

January 30, 2026

First Submitted That Met QC Criteria

February 17, 2026

First Posted (Actual)

February 20, 2026

Study Record Updates

Last Update Posted (Actual)

February 20, 2026

Last Update Submitted That Met QC Criteria

February 17, 2026

Last Verified

February 1, 2026

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 38299

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Restricted because they are disadvantaged group.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on HIV (Human Immunodeficiency Virus)

Clinical Trials on a reproductive health education program

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Trinidad & Tobago

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe